Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.03 +0.33 (+8.78%)
As of: Sep 29, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Non-Current Debt (2020 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) recorded Non-Current Debt of $4.75 million in Q2 2026, down 66.5% from $14.2 million a year earlier and down 33.8% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Non-Current Debt (2020 - 2026) Analysis & Trends

At the end of FY2025, Recursion Pharmaceuticals reported Non-Current Debt of $9.56 million, down 49.7% from FY2024.

  • Annual Non-Current Debt has a five-year compound annual growth rate of -3.5% (FY2020 to FY2025).
  • Across earlier years, Non-Current Debt came in at $19.02 million in FY2024, $1.1 million in FY2023 (+105.4%), $536,000 in FY2022 (-15.3%) and $633,000 in FY2021 (-94.5%).
  • The Q2 2026 figure is the lowest quarterly Non-Current Debt since Q1 2024.
  • On a year-over-year basis, Non-Current Debt has declined for five consecutive quarters, with an average decline of 50.5% over the last five quarters.
  • Peak year-over-year performance for Non-Current Debt in the last five years was growth of 105.4% in Q4 2023, against a decline of 94.5% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $7.18 million (Q1 2026), $9.56 million (Q4 2025) and $11.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn 4.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.75 Mn
Mar 31, 2026 7.18 Mn
Dec 31, 2025 9.56 Mn
Sep 30, 2025 11.90 Mn
Jun 30, 2025 14.20 Mn
Mar 31, 2025 16.45 Mn
Dec 31, 2024 19.02 Mn
Sep 30, 2024 20.51 Mn
Jun 30, 2024 22.92 Mn
Mar 31, 2024 1.07 Mn
Dec 31, 2023 1.10 Mn
Sep 30, 2023 1.13 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 1.18 Mn
Dec 31, 2022 536,000.00
Sep 30, 2022 561,000.00
Jun 30, 2022 586,000.00
Mar 31, 2022 610,000.00
Dec 31, 2021 633,000.00
Sep 30, 2021 656,000.00
API Access

Recursion Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RXRX&period=max&api_key=YOUR_API_KEY